Partner Perspectives | BioPharm Communications

How non-endemic platforms can help brand teams amplify their use of KOLs in HCP outreach

While COVID-driven challenges remain many, so do the carryover opportunities to redefine HCP engagement and communication.

Marketers are working to reimagine how they leverage key opinion leader (KOL) support during COVID-19.

Non-personal promotion is a foundational component of most brands’ omnichannel marketing strategy.

The current COVID-19 pandemic has taken the world of HCP marketing and turned it upside down. Biopharma has had to make instantaneous decisions on how to market in this new environment, who to market to, which tactics to significantly increase, and which tactics to walk away from-all with no historical playbook.

The impact of vacant sales territories on overall brand performance is often underestimated within pharma and biotech companies.

Pharma and biotech marketers are facing more challenges than ever in communicating brand messages to target healthcare professionals (HCPs).